🔎 Trials Near Me

Почетна › Рак на дојка › Њу Џерси › Edison

Клинички испитувања за Рак на дојка во Edison, NJ

68 студии за Рак на дојка бараат учесници на локации во и околу Edison (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Се регрутираФаза 3
  • Rutgers Cancer Institute, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06982521

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT05534438

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Се регрутираФаза 2
  • Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07102381

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07218250

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Се регрутираФаза 1
  • Research Site, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Се регрутираФаза 3
  • Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07060807

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Се регрутира
  • Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · на 5 милји
Возраст 30 и постари · Жени · Ажурирано 25.9.2026 · NCT02945579

A Study of Language Interpretation Solutions for People With Breast Cancer

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06721065

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Се регрутираФаза 3
  • Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06966700

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 24.9.2026 · NCT05412225

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Се регрутира
  • Rutgers, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07214532

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст 45 и постари · Жени · Ажурирано 21.9.2026 · NCT04084730

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Се регрутираФаза 1/2
  • Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Се регрутираФаза 3
  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), New Brunswick · на 3 милји
  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Somerville · на 11 милји
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Се регрутираФаза 3
  • Rutgers Cancer Institute, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT06246968

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Се регрутираФаза 1
  • START - New Jersey, East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Се регрутираФаза 1
  • Rutgers Cancer Institute, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06253871

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT05570253

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Се регрутираФаза 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT07100106

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

Се регрутираФаза 2
  • Astera Cancer Care East Brunswick, East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07368998

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Се регрутираФаза 3
  • Astera Cancer Care East Brunswick, East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT06790693

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Се регрутираНабљудувачка студија
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 3.9.2026 · NCT05590949

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Се регрутираФаза 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
  • MD Anderson Cancer Center at Cooper-Voorhees, Voorhees Township · на 5 милји
  • Virtua Voorhees, Voorhees Township · на 5 милји
  • и уште 1
Возраст од 18 до 60 · Жени · Ажурирано 2.9.2026 · NCT05879926

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Се регрутираФаза 2
  • Cooper Hospital University Medical Center, Voorhees Township · на 5 милји
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT07076485

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT05837767

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 27.8.2026 · NCT05716893

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Се регрутираФаза 1
  • START New Jersey, LLC, East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT07383506

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Се регрутираФаза 1
  • Rutgers Cancer Institute, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT05483491

A Study of Romosozumab in People With Breast Cancer and Osteoporosis

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 20.8.2026 · NCT07776613

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Се регрутираФаза 2
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT07459673

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 70 и постари · Сите полови · Ажурирано 17.8.2026 · NCT07768436

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Се регрутираФаза 3
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT06500481

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT06954337

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT07646847

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Се регрутираФаза 4
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 10.7.2026 · NCT07220967

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Се регрутира
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 9.7.2026 · NCT07335354

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Се регрутираФаза 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.6.2026 · NCT05696626

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Се регрутира
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-up), Basking Ridge · на 15 милји
Возраст од 18 до 64 · Жени · Ажурирано 12.6.2026 · NCT03572374

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 50 и постари · Жени · Ажурирано 4.6.2026 · NCT07483307

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 28.5.2026 · NCT06678269

Rutgers University Study of the Genetics of Breast Cancer.

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • Rutgers University, Piscataway · на 2 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06773897

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Се регрутираФаза 1/2
  • Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06686394

A Study of Blood Pressure Control During Cancer Treatment

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 14.5.2026 · NCT06023576

A Study of Surgery and Radiotherapy in People With Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 14.5.2026 · NCT07053085

Lymphedema Surveillance Study

Се регрутираНабљудувачка студија
  • Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 7.5.2026 · NCT02743858

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Се регрутираФаза 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Се регрутираФаза 3
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст од 50 до 70 · Сите полови · Ажурирано 23.4.2026 · NCT04852887

Factors Associated With Breast Cancer Risks and Outcomes

Се регрутираНабљудувачка студија
  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 17.4.2026 · NCT07294703

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Се регрутираНабљудувачка студија
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 4.3.2026 · NCT01788839

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 27.2.2026 · NCT03808337

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 25.2.2026 · NCT06099769

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 17.2.2026 · NCT04683679

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Се регрутираФаза 1/2
  • START, Astera, East Brunswick · на 6 милји
Возраст 18 и постари · Сите полови · Ажурирано 17.2.2026 · NCT07145255

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст 18 и постари · Сите полови · Ажурирано 11.2.2026 · NCT06623396

A Study of Revaree Plus in People With Breast Cancer

Се регрутираФаза 4
  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · на 15 милји
Возраст 18 и постари · Жени · Ажурирано 6.2.2026 · NCT07042581

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

Се регрутира
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
  • RWJBarnabas Health, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 21.1.2026 · NCT05736367

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Се регрутираНабљудувачка студија
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 20.1.2026 · NCT06401421

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Се регрутираФаза 4
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст од 18 до 65 · Сите полови · Ажурирано 30.12.2025 · NCT07308717

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

Се регрутираФаза 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville · на 11 милји
Возраст 60 и постари · Жени · Ажурирано 14.11.2025 · NCT06139107

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Се регрутираФаза 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset · на 4 милји
Возраст 18 и постари · Жени · Ажурирано 14.11.2025 · NCT05559164

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Се регрутираФаза 4
  • Jack and Sheryl Morris Cancer Center, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospita, New Brunswick · на 3 милји
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville · на 11 милји
Возраст 18 и постари · Сите полови · Ажурирано 13.11.2025 · NCT07158164

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Се регрутираФаза 3
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Возраст од 18 до 75 · Жени · Ажурирано 10.11.2025 · NCT06144164

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Се регрутираНабљудувачка студија
  • Massive Bio SYNERGY-AI site, New Brunswick · на 3 милји
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Возраст од 18 до 44 · Жени · Ажурирано 14.10.2025 · NCT00823654

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Се регрутираФаза 1
  • Rutgers University, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2025 · NCT05216432

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • Exelixis Clinical Site #9, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 5.9.2025 · NCT05932862

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Се регрутираФаза 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Возраст 18 и постари · Сите полови · Ажурирано 19.6.2025 · NCT06568692

Испитувања за Рак на дојка во други градови

Други студии во Edison

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.